Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug

Details for Australian Patent Application No. 2004234003 (hide)

Owner Baxter International Inc.

Inventors Rabinow, Barrett E.; Rebbeck, Christine L.; Kipp, James E.; Sun, Chong-Son; Wong, Joseph Chung Tak; Doty, Mark J.; Papadopoulos, Pavlos; White, Randy

Agent Peter Maxwell & Associates

Pub. Number AU-A-2004234003

PCT Pub. Number WO2004/096180

Priority 60/466,354 29.04.03 US

Filing date 29 April 2004

Wipo publication date 11 November 2004

International Classifications

A61K 009/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 009/51 Medicinal preparations characterised by special physical form - Nanocapsules

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/096180 Priority application(s): WO2004/096180

26 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004234004-Surgical stapling device with dissecting tip

2004234001-Medical device with antimicrobial layer